Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -25.9% | -6.0% | 1 / 3 | +7.8% | +2.43 pp | -0.05 pp | +26.3% | 0.00 | 5.52 | 1.307 | +7,8% | 7,6 | −1,0% | 5.52 | 8.15 | −32,3% |
| Pts | 0 | 0 | 4 | 0 | 8 | 4 | 12 | 12 | 12 | |||||||
Valuation annotation:Price: 25.500 (close price on 2026-10-15)EPS (TTM): 4.623
Financial charts
1.Revenue & growth
VND bn1.307Q2/26
1.Revenue & growth
VND bn1.307Q2/26
2.Profit & growth
VND bn7,81Q2/26
3.Profit mix (Penman)
VND bn76,7Q2/26
4.Margins & cost structure
%27.2%Q2/26
5.Returns & cash cycle
% · days26.8%Q2/26
6.Earnings quality & cash
VND bn128Q2/26
7.Asset structure
VND bn2.104Q2/26
8.Funding & debt health
VND bn · times2.104Q2/26
9.Revenue backlog
VND bn39,5Q2/26
10.Valuation
times · %7,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %612Q2/26
Adjusted EPS growth, latest quarter
2.9%
Average adjusted EPS growth, 3 quarters
3.5%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26